Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology
NCT ID: NCT06788821
Last Updated: 2025-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
440 participants
OBSERVATIONAL
2024-06-12
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is:
Is it possible to diagnose thyroid disease in fetuses early using measurable parameters of the fetal thyroid through ultrasonography?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fetal Thyroid Ultrasound And Fetal Thyroid Hormones
NCT02017080
Evaluation of Patients With Hypertensive Disorders of Pregnancy: An Ambispective Observational Study
NCT07299773
The Role of Ultrasonography in Predicting Outcomes of Fetal Nephropathy
NCT06806644
Third Trimester Screening of Fetal Growth Restriction
NCT05787054
Relation Between Subclinical Hypothyroidism and Outcome of Pregnancy
NCT01335802
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The present study will provide more information about the possibility to use prenatal ultrasonography for diagnosis and prognostic guidance in cases of suspected fetal thyroid changes. In the latter case, we will be able to more accurately delineate the indication for serious prenatal ultrasound checks, guide counseling with the parental couple, addressing them to possible consultation with pediatric specialist.
Women will be asked to undergo a single ultrasound scan, as per normal clinical practice. With the ultrasound scan it will also be possible to assess parameters that will allow the study of the biometry, morphology and volume of fetal thyroid.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low obstetric risk
i.e., pregnancy with a regular course and not complicated by maternal and/or fetal pathology
Description of the trend of major thyroid ultrasound biometric parameters
Use of prenatal ultrasonography for diagnosis and prognostic guidance in suspected fetal thyroid changes.
Hypertyroidism
Group con participants with hypertyroidism
Description of the trend of major thyroid ultrasound biometric parameters
Use of prenatal ultrasonography for diagnosis and prognostic guidance in suspected fetal thyroid changes.
Hypothyroidism
Group of participants with hypothyroidism
Description of the trend of major thyroid ultrasound biometric parameters
Use of prenatal ultrasonography for diagnosis and prognostic guidance in suspected fetal thyroid changes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Description of the trend of major thyroid ultrasound biometric parameters
Use of prenatal ultrasonography for diagnosis and prognostic guidance in suspected fetal thyroid changes.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Obtaining informed consent for participation in the study
* Maternal age between 18 and 45 years (extremes included)
* Participants with good understanding of the Italian language
Exclusion Criteria
* Patients with BMI\>30
* Absence of correct dating of pregnancy within the first trimester
* Pathological conditions (e.g., malabsorptive or socioeconomic conditions that may interfere with fetal growth)
* Twin pregnancy
* Only for the low obstetric risk group of patients: Fetus with malformative pathology
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elena Contro, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, Italy
Ospedale Santa Chiara - Trento
Trento, Italy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FETAL THYROID
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.